Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) EBT (2016 - 2025)

Bio Key International (BKYI) has disclosed EBT for 16 consecutive years, with -$964849.0 as the latest value for Q3 2025.

  • Quarterly EBT fell 30.57% to -$964849.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$4.3 million through Sep 2025, up 23.17% year-over-year, with the annual reading at -$4.3 million for FY2024, 50.05% up from the prior year.
  • EBT hit -$964849.0 in Q3 2025 for Bio Key International, up from -$1.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$510285.0 in Q1 2024 to a low of -$6.8 million in Q4 2022.
  • Historically, EBT has averaged -$1.7 million across 5 years, with a median of -$1.4 million in 2024.
  • Biggest five-year swings in EBT: soared 76.36% in 2021 and later tumbled 240.64% in 2022.
  • Year by year, EBT stood at -$2.0 million in 2021, then crashed by 240.64% to -$6.8 million in 2022, then skyrocketed by 61.09% to -$2.6 million in 2023, then soared by 46.88% to -$1.4 million in 2024, then surged by 31.45% to -$964849.0 in 2025.
  • Business Quant data shows EBT for BKYI at -$964849.0 in Q3 2025, -$1.2 million in Q2 2025, and -$736545.0 in Q1 2025.